Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avidity Biosciences, Inc.

30.61
-0.0150-0.05%
Volume:377.23K
Turnover:11.54M
Market Cap:3.69B
PE:-10.11
High:31.00
Open:30.14
Low:30.00
Close:30.62
Loading ...

Avidity Biosciences: Accelerated Approval Path Confirmed for Del-Zota; Bla Submission Planned for Year End 2025

THOMSON REUTERS
·
08 Jan

Press Release: Avidity Biosciences Plans First BLA Submission and Accelerates Commercialization Preparations for Three Rare Muscle Disease Programs in 2025

Dow Jones
·
08 Jan

Tempus AI teams with Genialis to develop RNA-based biomarker algorithms

TIPRANKS
·
08 Jan

Tempus Announces a Collaboration With Genialis to Develop RNA-Based Biomarker Algorithms

Business Wire
·
08 Jan

Orna Therapeutics Establishes Strategic Collaboration with Vertex Pharmaceuticals to Develop Next Generation Approaches for Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)

PR Newswire
·
07 Jan

Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic

Benzinga
·
04 Jan

Why Is Avidity Biosciences, Inc. (RNA) Among the Best Multibagger Stocks to Buy Right Now?

Insider Monkey
·
02 Jan

Covid RNA Analyzed With Tee on OVM: Open (Incl. RSS3) Supercharges DeSci

TIPRANKS
·
31 Dec 2024

Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA

GlobeNewswire
·
31 Dec 2024

Veritas In Silico's RNA Function Control Patent Gains European Recognition

MT Newswires Live
·
30 Dec 2024

Veritas In Silico Secures European Patent for RNA Discovery

TIPRANKS
·
30 Dec 2024

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PR Newswire
·
21 Dec 2024

HC Wainwright Initiates Coverage on Avidity Biosciences With Buy Rating, $72 Price Target

MT Newswires Live
·
20 Dec 2024

Avidity Biosciences initiated with a Buy at H.C. Wainwright

TIPRANKS
·
20 Dec 2024

Avidity Biosciences Inc : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $72

THOMSON REUTERS
·
20 Dec 2024

Avidity Biosciences CEO Boyce sells 31,855 common shares

TIPRANKS
·
20 Dec 2024

Circio Secures Funding to Boost RNA Technology Development

TIPRANKS
·
19 Dec 2024

Jefferies healthcare analyst holds an analyst/industry conference call

TIPRANKS
·
19 Dec 2024

Circio Holding ASA Pioneers RNA Technology and Cancer Vaccine

TIPRANKS
·
17 Dec 2024

Avidity Biosciences (RNA) Receives a Buy from TD Cowen

TIPRANKS
·
13 Dec 2024